These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10471782)

  • 1. Enhanced anti-HIV-1 activity of CC-chemokine LD78beta, a non-allelic variant of MIP-1alpha/LD78alpha.
    Xin X; Shioda T; Kato A; Liu H; Sakai Y; Nagai Y
    FEBS Lett; 1999 Aug; 457(2):219-22. PubMed ID: 10471782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The LD78beta isoform of MIP-1alpha is the most potent CC-chemokine in inhibiting CCR5-dependent human immunodeficiency virus type 1 replication in human macrophages.
    Aquaro S; Menten P; Struyf S; Proost P; Van Damme J; De Clercq E; Schols D
    J Virol; 2001 May; 75(9):4402-6. PubMed ID: 11287590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LD78beta, a non-allelic variant of human MIP-1alpha (LD78alpha), has enhanced receptor interactions and potent HIV suppressive activity.
    Nibbs RJ; Yang J; Landau NR; Mao JH; Graham GJ
    J Biol Chem; 1999 Jun; 274(25):17478-83. PubMed ID: 10364178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LD78beta isoform of MIP-1alpha is the most potent CCR5 agonist and HIV-1-inhibiting chemokine.
    Menten P; Struyf S; Schutyser E; Wuyts A; De Clercq E; Schols D; Proost P; Van Damme J
    J Clin Invest; 1999 Aug; 104(4):R1-5. PubMed ID: 10449444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
    Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
    Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage by CD26/dipeptidyl peptidase IV converts the chemokine LD78beta into a most efficient monocyte attractant and CCR1 agonist.
    Proost P; Menten P; Struyf S; Schutyser E; De Meester I; Van Damme J
    Blood; 2000 Sep; 96(5):1674-80. PubMed ID: 10961862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolysis of macrophage inflammatory protein-1alpha isoforms LD78beta and LD78alpha by neutrophil-derived serine proteases.
    Ryu OH; Choi SJ; Firatli E; Choi SW; Hart PS; Shen RF; Wang G; Wu WW; Hart TC
    J Biol Chem; 2005 Apr; 280(17):17415-21. PubMed ID: 15728180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Macrophage inflammatory protein-1.
    Menten P; Wuyts A; Van Damme J
    Cytokine Growth Factor Rev; 2002 Dec; 13(6):455-81. PubMed ID: 12401480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemokine PARC gene (SCYA18) generated by fusion of two MIP-1alpha/LD78alpha-like genes.
    Tasaki Y; Fukuda S; Iio M; Miura R; Imai T; Sugano S; Yoshie O; Hughes AL; Nomiyama H
    Genomics; 1999 Feb; 55(3):353-7. PubMed ID: 10049593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of amino acid residues critical for LD78beta, a variant of human macrophage inflammatory protein-1alpha, binding to CCR5 and inhibition of R5 human immunodeficiency virus type 1 replication.
    Miyakawa T; Obaru K; Maeda K; Harada S; Mitsuya H
    J Biol Chem; 2002 Feb; 277(7):4649-55. PubMed ID: 11734558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The CXC chemokine SDF-1 is the ligand for LESTR/fusin and prevents infection by T-cell-line-adapted HIV-1.
    Oberlin E; Amara A; Bachelerie F; Bessia C; Virelizier JL; Arenzana-Seisdedos F; Schwartz O; Heard JM; Clark-Lewis I; Legler DF; Loetscher M; Baggiolini M; Moser B
    Nature; 1996 Aug; 382(6594):833-5. PubMed ID: 8752281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-chemokines that inhibit HIV-1 infection of human macrophages stimulate uptake and promote destruction of Trypanosoma cruzi by human macrophages.
    Lima MF; Zhang Y; Villalta F
    Cell Mol Biol (Noisy-le-grand); 1997 Nov; 43(7):1067-76. PubMed ID: 9449540
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of HIV type 1 BaL replication by MIP-1alpha, MIP-1beta, and RANTES in macrophages.
    Capobianchi MR; Abbate I; Antonelli G; Turriziani O; Dolei A; Dianzani F
    AIDS Res Hum Retroviruses; 1998 Feb; 14(3):233-40. PubMed ID: 9491913
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of CC chemokine receptor 5 (CCR5)-tropic human immunodeficiency virus-1 replication in human lymphoid tissue by CC chemokines.
    Margolis LB; Glushakova S; Grivel JC; Murphy PM
    J Clin Invest; 1998 May; 101(9):1876-80. PubMed ID: 9576751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CC CKR5: a RANTES, MIP-1alpha, MIP-1beta receptor as a fusion cofactor for macrophage-tropic HIV-1.
    Alkhatib G; Combadiere C; Broder CC; Feng Y; Kennedy PE; Murphy PM; Berger EA
    Science; 1996 Jun; 272(5270):1955-8. PubMed ID: 8658171
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Difference in susceptibility to CC-chemokines among HIV-1 isolates.
    Gao M; Tsuchie H; Jin TQ; Zhang J; Detorio MA; Hossain MM; Taniguchi K; Kurimura T
    Int J STD AIDS; 1998 Aug; 9(8):471-5. PubMed ID: 9702596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide regulates MIP-1alpha expression in primary macrophages and T lymphocytes: implications for anti-HIV-1 response.
    Sherry B; Schmidtmayerova H; Zybarth G; Dubrovsky L; Raabe T; Bukrinsky M
    Mol Med; 2000 Jun; 6(6):542-9. PubMed ID: 10972089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Macrophage inflammatory protein-1alpha (MIP-1alpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1.
    Lu Y; Xin KQ; Hamajima K; Tsuji T; Aoki I; Yang J; Sasaki S; Fukushima J; Yoshimura T; Toda S; Okada E; Okuda K
    Clin Exp Immunol; 1999 Feb; 115(2):335-41. PubMed ID: 9933462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of both the V2 and V3 regions of the CCR5-tropic human immunodeficiency virus type 1 envelope in reduced sensitivity to macrophage inflammatory protein 1alpha.
    Maeda Y; Foda M; Matsushita S; Harada S
    J Virol; 2000 Feb; 74(4):1787-93. PubMed ID: 10644351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.